HIV-prevention drug to be available for $40 a year from 2027

Generic versions of a groundbreaking injectable HIV-prevention drug should be available for $40 a year in more than 100 ...
France 24

'We can end HIV': Groundbreaking preventative drug to be rolled out for $40 a year from 2027

Global health agencies announced Wednesday that generic versions of a groundbreaking injectable drug to prevent HIV will be ...
Medical Dialogues

Study suggests some maternal HIV infections may be missed during pregnancy

Newborns exposed to HIV during pregnancy or birth should receive preventive antiretroviral medication immediately after ...
MyJoyOnline

Ahafo Region records 636 new cases of HIV infections in 6 months

A total of 636 new cases of Human Immunodeficiency Virus (HIV) infections have been recorded in the Ahafo Region in the first ...

HIV: Highly effective drug lenacapavir to be offered at just $40 a year

This antiretroviral has shown unprecedented results in HIV prevention, requiring only two injections per year. Its ...
PharmiWeb

Global HIV Diagnostics Market Expected to Achieve Robust Growth Momentum With 10% CAGR 2030

The global HIV diagnostics market is expected to grow at a CAGR of ~10% during the forecast period. Rising prevalence of HIV ...

HIV-prevention drug to cost $40 a year from 2027

The two organizations have signed separate agreements with Indian pharmaceutical companies to produce cheaper generics of lenacapavir - a twice-yearly injection shown to reduce the risk of HIV ...

Landmark deals for cheaper ‘pandemic-ending’ HIV jab hailed as ‘huge’ step forward

Linda-Gail Bekker, who helped prove the drug Lenacapavir’s effectiveness, tells The Independent that $40 doses bring hope – ...